Genetics Institute Inc.

Company Information

Company Name
Genetics Institute Inc.
Address
87 Cambridge Park Drive
Cambridge, MA, 02140
Phone
n/a
URL
n/a
DUNS
n/a
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$240,000.00
5
SBIR Phase II
$1,169,000.00
3
Chart code to be here

Award List

  1. STABILIZATION OF ENZYMES BY ATTACHMENT TO SOLUBLE POLYMERS

    Amount: $200,000.00

    HYPOTHESES ABOUT THE STABILIZATION OF ENZYMES BY COVALENT ATTACHMENT TO SOLUBLE POLYMERS ARE TO BE TESTED IN DETAIL TO ISOLATE THE EFFECT OF MULTI-POINT ATTACHMENT FROM OTHER FACTORS KNOWN TO AFFECT E ...

    SBIR Phase II 1987 National Science Foundation
  2. GENETIC ENGINEERING OF AN IMPROVED FACTOR VIII PRODUCT

    Amount: $500,000.00

    FACTOR VIII IS THE PLASMA PROTEIN THAT IS FUNCTIONALLY DEFICIENT IN HEMOPHILIA A PATIENTS, RESULTING IN THE CLINICAL BLEEDING DISORDER. PATIENTS WITH THIS DISEASE REQUIRE FREQUENT INFUSIONS OF FACTOR ...

    SBIR Phase II 1988 Department of Health and Human Services
  3. CURRENT TECHNIQUES FOR THE DIAGNOSIS OF GENETIC DISEASE ARE LIMITED BY AN INABILITY TO DETECT THE MAJORITY OF MUTATIONS AND POLYMORPHISMS IN DNA.

    Amount: $50,000.00

    CURRENT TECHNIQUES FOR THE DIAGNOSIS OF GENETIC DISEASE ARE LIMITED BY AN INABILITY TO DETECT THE MAJORITY OF MUTATIONS AND POLYMORPHISMS IN DNA. DNA MOLECULES THAT DIFFER BY ONE OR A FEW BASE PAIRS C ...

    SBIR Phase I 1986 Department of Health and Human Services
  4. PRODUCTION OF HUMAN MONOCLONAL ANTIBODIES IN TRANSGENIC MICE

    Amount: $469,000.00

    MONOCLONAL ANTIBODIES HAVE IMMENSE POTENTIAL FOR USE AS PROPHYLACTIC, DIAGNOSTIC, AND THERAPEUTIC AGENTS IN THE TREATMENT OF VARIOUS TYPES OF HUMAN AILMENTS. FOR MANY USESIT IS DESIRABLE TO USE HUMAN ...

    SBIR Phase II 1988 Department of Health and Human Services
  5. THE OBJECTIVE OF THE PROJECT IS TO ESTABLISH HUMAN HEMATO- POIETIC PROGENITOR GROWTH FACTOR-DEPENDENT CELL LINES IN CULTURE.

    Amount: $50,000.00

    THE OBJECTIVE OF THE PROJECT IS TO ESTABLISH HUMAN HEMATO- POIETIC PROGENITOR GROWTH FACTOR-DEPENDENT CELL LINES IN CULTURE. TO ACCOMPLISH THIS, RESEARCHERS WILL FIRST DESIGN AND CONSTRUCT RETROVIRAL ...

    SBIR Phase I 1986 Department of Health and Human Services
  6. PRODUCTION OF HUMAN MONOCLONAL ANTIBODIES IN TRANSGENIC MICE

    Amount: $50,000.00

    N/A

    SBIR Phase I 1986 Department of Health and Human Services
  7. STABILIZATION OF ENZYMES BY ATTACHMENT TO SOLUBLE POLYMERS

    Amount: $40,000.00

    N/A

    SBIR Phase I 1984 National Science Foundation
  8. GENETIC ENGINEERING OF AN IMPROVED FACTOR VIII PRODUCT

    Amount: $50,000.00

    N/A

    SBIR Phase I 1986 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government